drugset / Trial / NCT00486031
Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study
NaSingle-groupOpen-labelSupportive care
Summary
The objective of the study is to evaluate the long-term safety and tolerability of treatment with balsalazide disodium tablets in subjects who are in remission from ulcerative colitis or who have mildly to moderately active UC.
Timeline
- Start
- 2006-10
- Primary completion
- 2008-04
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Balsalazide | Small molecule | 3.3 g | — |